1. Hunstad JP, Shifrin DA, Kortesis BG. Successful treatment of Parry-Romberg syndrome with autologous fat grafting: 14-year follow-up and review. Ann Plast Surg. 2011; 67:423–425.
Article
2. Balaji SM. Subdermal fat grafting for Parry-Romberg syndrome. Ann Maxillofac Surg. 2014; 4:55–59.
Article
3. Agostini T, Spinelli G, Marino G, Perello R. Esthetic restoration in progressive hemifacial atrophy (Romberg disease): structural fat grafting versus local/free flaps. J Craniofac Surg. 2014; 25:783–787.
4. Alencar JC, Andrade SH, Pessoa SG, Dias IS. [Autologous fat transplantation for the treatment of progressive hemifacial atrophy (Parry-Romberg syndrome: case report and review of medical literatute)]. An Bras Dermatol. 2011; 86:4 Suppl 1. S85–S88. Portuguese.
5. Chang Q, Li J, Dong Z, Liu L, Lu F. Quantitative volumetric analysis of progressive hemifacial atrophy corrected using stromal vascular fraction-supplemented autologous fat grafts. Dermatol Surg. 2013; 39:1465–1473.
6. Myung Y, Lee YH, Chang H. Surgical correction of progressive hemifacial atrophy with onlay bone graft combined with soft tissue augmentation. J Craniofac Surg. 2012; 23:1841–1844.
Article
7. Cox SE, Soderberg JM. Idiopathic hemifacial atrophy treated with serial injections of calcium hydroxylapatite. Dermatol Surg. 2010; 36:542–545.
Article
8. Tollefson MM, Witman PM. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol. 2007; 56:257–263.
Article
9. Chai G, Tan A, Yao CA, Magee WP 3rd, Junjun P, Zhu M, et al. Treating Parry-Romberg syndrome using three-dimensional scanning and printing and the anterolateral thigh dermal adipofascial flap. J Craniofac Surg. 2015; 26:1826–1829.
Article
10. Yu-Feng L, Lai G, Zhi-Yong Z. Combined treatments of facial contour deformities resulting from Parry-Romberg syndrome. J Reconstr Microsurg. 2008; 24:333–342.
Article
11. Al-Niaimi F, Taylor JA, Lyon CC. Idiopathic hemifacial atrophy treated with permanent polyacrylamide subdermal filler. Dermatol Surg. 2012; 38:143–145.
Article
12. Park S, Park KY, Yeo IK, Cho SY, Ah YC, Koh HJ, et al. Investigation of the degradation-retarding effect caused by the low swelling capacity of a novel hyaluronic Acid filler developed by solid-phase crosslinking technology. Ann Dermatol. 2014; 26:357–362.
Article
13. Bugge H, Negaard A, Skeie L, Bergersen B. Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients. HIV Med. 2007; 8:475–482.
Article
14. Becker M, Balague N, Montet X, Calmy A, Salomon D, Toutous-Trellu L. Hyaluronic Acid filler in HIV-associated facial lipoatrophy: evaluation of tissue distribution and morphology with MRI. Dermatology. 2015; 230:367–374.
Article
15. Verpaele A, Strand A. Restylane SubQ, a non-animal stabilized hyaluronic acid gel for soft tissue augmentation of the mid- and lower face. Aesthet Surg J. 2006; 26(1s):S10–S17.
Article
16. Lee BM, Han DG, Choi WS. Rejuvenating effects of facial hydrofilling using restylane vital. Arch Plast Surg. 2015; 42:282–287.
Article